Current Role of Hormonal Treatment in Prostate Cancer


  • Bannakij Lojanapiwat Division of Urology, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand


Current Role, Hormonal Treatment, Prostate Cancer




Huggins C, Hodges CV. Studies on prostate cancer: the effect of castration, of estrogen, and of androgen injection on serum phosphatase in metastasis carcinoma of prostate-1941. J Urol 2002; 168: 9-12.

EAU Guidelines 2008 edition P65.

Melton LJ. Declined in bilateral orchiectomy for prostate cancer in Olmsted county, Minesota. Mayo Clinic Proc 2001.

Trachtenberg J .Endocrine therapy: non-estrogen pharmacological manipulation. Siminar Urol 1983; 1: 288-90.

Jacobi et al. Treatment of advanced prostate cancer with parenteral cyprosterone acetate. Br J Urol 1980; 52: 208-15.

Barradell et al. Cyprosterone, A review of its pharmacology and therapeutic efficacy in prostate cancer. Drug Aging 1994; 5: 59-80.

Neri RO. Antiandrogen 1976; 2: 233-62.

Schellhammer PF,David JW.An evaluation of bicalutamide in the treatment of prostate cancer. Clin Prostate Cancer 2004; 2:213-9.

Weckerman D, Harzmann R. Hormone therapy in prostate cancer: LHRH agonist versus LHRH analogue. Eur Urol 2004; 46: 279-83.

Conde FA et al. Risk factors for male osteoporosis. Urol Oncol 21:380-3.

Cervenakov I, çHot flush çAn unpleasant symptom accompany antiandrogen therapy of patient of prostate. Int Uro Nephrol 2000; 32: 77-9.




How to Cite

Lojanapiwat, B. (2009). Current Role of Hormonal Treatment in Prostate Cancer. Insight Urology, 30(2), 39–43. Retrieved from



Review article